Literature DB >> 23510940

Developmental alterations in the biophysical properties of Ca(v) 1.3 Ca(2+) channels in mouse inner hair cells.

Akira Inagaki1, Amy Lee.   

Abstract

Prior to hearing onset, spontaneous action potentials activate voltage-gated Cav 1.3 Ca ( 2+) channels in mouse inner hair cells (IHCs), which triggers exocytosis of glutamate and excitation of afferent neurons. In mature IHCs, Cav 1.3 channels open in response to evoked receptor potentials, causing graded changes in exocytosis required for accurate sound transmission. Developmental alterations in Cav 1.3 properties may support distinct roles of Cav 1.3 in IHCs in immature and mature IHCs, and have been reported in various species. It is not known whether such changes in Cav 1.3 properties occur in mouse IHCs, but this knowledge is necessary for understanding the roles of Cav 1.3 in developing and mature IHCs. Here, we describe age-dependent differences in the biophysical properties of Cav 1.3 channels in mouse IHCs. In mature IHCs, Cav 1.3 channels activate more rapidly and exhibit greater Ca ( 2+) -dependent inactivation (CDI) than in immature IHCs. Consistent with the properties of Cav 1.3 channels in heterologous expression systems, CDI in mature IHCs is not affected by increasing intracellular Ca ( 2+) buffering strength. However, CDI in immature IHCs is significantly reduced by strong intracellular Ca ( 2+) buffering, which both slows the onset of, and accelerates recovery from, inactivation. These results signify a developmental decline in the sensitivity of CDI to global elevations in Ca ( 2+) , which restricts negative feedback regulation of Cav 1.3 channels to incoming Ca ( 2+) ions in mature IHCs. Together with faster Cav 1.3 activation kinetics, increased reliance of Cav 1.3 CDI on local Ca ( 2+) may sharpen presynaptic Ca ( 2+) signals and improve temporal aspects of sound coding in mature IHCs.

Entities:  

Keywords:  Ca2+ channel; calmodulin; inner hair cell

Mesh:

Substances:

Year:  2013        PMID: 23510940      PMCID: PMC3710344          DOI: 10.4161/chan.24104

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


Introduction

Voltage-gated Cav Ca2+ channels conduct inward Ca2+ currents that can depolarize the membrane potential and trigger Ca2+-dependent signal transduction in excitable cells. Multiple classes of Cav channels (Cav1.x-Cav3.x) have been characterized, which play distinct roles often within the same cell. In most neurons, somatodendritic Cav1 channels mediate L-type Ca2+ currents that couple neuronal activity to changes in gene transcription,, while presynaptic Cav2 channels generating P/Q- and N-type Ca2+ currents regulate neurotransmitter release from nerve terminals.- In contrast to the diverse complement of Cav channnels in most neuronal cell-types, auditory hair cells express predominantly Cav1.3 channels, which mediate exocytosis of glutamate at ribbon synapses formed with primary afferent neurons., Genetic inactivation of CACNA1D (Cav1.3 KO), which encodes the pore-forming α1 subunit of Cav1.3, causes ~90% reduction in the whole-cell Ca2+ current in mouse inner hair cells (IHCs).- As a consequence, stimulus-secretion coupling is significantly impaired in Cav1.3 KO IHCs, which contributes to deafness in these mice., Spontaneous Ca2+-dependent action potentials, which support presensory afferent synaptic transmission,- are absent in Cav1.3 KO IHCs. The developmental upregulation of BK K+ channels and pruning of cholinergic efferents from the basal IHC membrane, which normally occurs around the onset of hearing,, are also absent in Cav1.3 KO IHCs., Thus, Cav1.3 channels play distinct roles in regulating electrical activity and normal developmental programs in immature IHCs, and in transducing stimulus-evoked exocytosis in mature IHCs. Comparisons of Cav1 currents in mature and immature auditory hair cells suggest differences in the properties of Cav1.3 channels that may tailor Ca2+ signals according to developmental stage. For example, in gerbil and rat IHCs, the extent to which Cav1 channels undergo Ca2+-dependent inactivation (CDI) declines after hearing onset., CDI is a negative feedback regulation of Cav1 and Cav2 channels by incoming Ca2+ ions, which depends on calmodulin binding to the Cav α1 subunit., CDI is relatively weak for Cav1 channels in IHCs, which may be due to the antagonistic actions of calmodulin-like Ca2+ binding proteins expressed in IHCs.,, The rates of Cav1 channel activation and inactivation can significantly influence IHC Ca2+ signals that regulate presensory action potentials or stimulus-secretion coupling. Whether Cav1.3 channels in mouse IHCs undergo developmental changes in their biophysical properties is incompletely characterized. Given the widespread use of mice as experimental models for IHC transmission, filling this void is essential for understanding Ca2+-dependent signaling in IHCs in this species. In this study, we compared the properties of Ca2+ and Ba2+ currents (ICa and IBa, respectively) in IHCs from mice before and after hearing onset (~P12). We discovered that Cav1.3 channels exhibit significant differences in immature (P6–8) and mature (P16–18) IHCs in terms of activation and inactivation. In particular, CDI differs in magnitude and sensitivity to local rather than global Ca2+ elevations in Ca2+. Our results highlight age-dependent distinctions in the properties of Cav1.3 channels that may fine-tune Ca2+ signals required for the development and mature function of IHCs.

Results

Cav1.3 currents activate with faster kinetics in mature IHCs than in immature IHCs

Because a goal of this study was to compare CDI before and after hearing onset in mouse IHCs, we first analyzed activation of both ICa and IBa in P6–8 and P16–18 mouse IHCs. Whole-cell patch clamp recordings were performed at room temperature in solutions designed to isolate Cav1.3 currents from other ionic currents, particularly voltage-gated K+ currents (see Materials and Methods). The intracellular solution contained 2 mM EGTA, which is permissive for measuring CDI in IHCs., Relatively high concentrations of extracellular Ca2+ or Ba2+ were used (5 mM) to amplify current amplitudes, thus increasing resolution of activation and inactivation kinetics. Consistent with previous studies of Cav1 channels in other cell-types, ICa underwent a progressive increase in amplitude (run-up) upon attaining whole-cell configuration in immature IHCs (Fig. 1). For this reason, we first monitored the amplitude of ICa evoked by steps to +10 mV every 20 sec until there was no further run-up. Interestingly, run-up was not observed in mature IHCs, which was confirmed by the same protocol. Thus, data were collected ~5 min after whole cell patch rupture in immature IHCs, when steady-state ICa amplitudes were achieved. In mature IHCs, data were collected ~1 min after patch rupture to ensure equilibration with intracellular solution components.

Figure 1. Run-up of ICa in immature mouse IHCs. (A) Representative current traces for ICa evoked by 20-ms test pulses to +10 mV, 10 sec and ~4 min after patch rupture. (B) ICa was normalized to that at 4 min after patch rupture and plotted against time.

Figure 1. Run-up of ICa in immature mouse IHCs. (A) Representative current traces for ICa evoked by 20-ms test pulses to +10 mV, 10 sec and ~4 min after patch rupture. (B) ICa was normalized to that at 4 min after patch rupture and plotted against time. As noted previously,, the most dramatic difference in Cav1.3 currents was the smaller amplitude of ICa and IBa in mature IHCs compared with immature IHCs. In current-voltage (I-V) relationships, the maximum current amplitude was obtained with a −10-mV pulse for ICa and was significantly smaller in mature IHCs than in immature IHCs (19.4 ± 15.4%; Figure 2A–D). A similar difference was observed for IBa (32.9 ± 10.2%) except that the peak IBa was obtained between −10 and −0 mV, due to changes in surface charge screening when Ba2+ rather than Ca2+ is used as the permeant ion. As has been reported for Cav1.3 in heterologous expression systems, there was some rectification in the I-V relationship at positive voltages, probably due to limited permeability of Cav1.3 channels to Cs+ ions. Thus for greater accuracy, we measured parameters for voltage-dependent activation in normalized tail current-voltage relationships fit with the Boltzmann equation. By this analysis, the voltage for half-maximal activation (V) was more positive and there was a significant increase in the slope factor (k) with age for ICa and IBa (Table1, Fig. 2E and F). In addition, the activation kinetics of ICa were significantly faster in mature IHCs than in immature IHCs (~5–29% from −40 mV to +40 mV, p < 0.001 by two-way ANOVA; Fig. 3A). The acceleration in Cav1.3 activation depended on Ca2+ as the charge carrier since it was not observed for IBa (p = 0.34 by two-way ANOVA; Fig. 3B). These results indicate that, in addition to a reduction in Cav1.3 current density, the intrinsic biophysical properties of Cav1.3 channels also change with development.

Figure 2. Voltage-dependent properties of ICa and IBa in mature IHCs and in immature IHCs. (A and B) Representative ICa (upper panels) and IBa (lower panels). Currents were evoked by 15– ms depolarizing pulses from a holding voltage of −84 mV. (C and D) I-V relationships for currents in (A). (E and F) G-V relationships for currents in (A and B). Tail current amplitudes were normalized to that obtained with a pulse to +50 mV (Norm. tail) and plotted against test voltage. Smooth lines in (C–F) represent curve fits from the Boltzmann equation. The parameters for the fits shown were: in (C), V = −26.6, k = −5.9, Vrev = 56.4 mV, Gmax = 4.3 nS for P6–8 (n = 22), V = −27.7, k = −5.4, Vrev = 56.1 mV, Gmax = 3.2 nS for P16–18 (n = 15); in (D), V = -32.8, k = −4.9, Vrev = 55.5 mV, Gmax = 4.3 for P6–8 (n = 22), V = −30.1 mV, k = −4.7, Vrev = 48.0 mV, Gmax = 3.3 for P16–18 (n = 15); in (E), V = −24.1 mV, k = 9.5 for P6–8 (n = 22), V = −19.0 mV, k = 13.1 for P16–18 (n = 9); in (F), V = −29.2 mV, k = 8.4 for P6–8 (n = 11), V = −23.2 mV, k = 9.6 for P16–18 (n = 15).

Table 1. Parameters for voltage-dependent activation of Cav1.3 currents in mouse IHCs

  P6–8nP16–18np-value1
ICa(2 mM EGTA)
Peak current density2 (pA/pF)
−35.6 ±1.8(at −10 mV)
22
−23.0 ±1.2(at −10 mV)
15
< 0.001
V1/2 (mV)3
−24.1 ± 0.9
−19.0 ± 1.8
9
0.009
k3
9.5 ± 0.3
13.1 ± 0.7
< 0.001
 
 
 
 
IBa(2 mM EGTA)
Peak current density2 (pA/pF)
−36.2 ± 1.8(at −10mV)
11
−21.7 ± 1.2(at −10mV)
15
< 0.001
V1/2 (mV)3
−29.2 ± 1.1
−23.2 ± 0.9
< 0.001
k3
8.4 ± 0.3
9. ± 0.3
0.011
 
 
 
 
ICa(10 mM BAPTA)Peak current density2(pA/pF)
−34.5 ± 1.3(at −10 mV)
25−20.0 ± 0.8(at −10 mV)
8< 0.001
V1/2 (mV)3
−24.4 ± 0.6
−18.6 ± 0.9
< 0.001
k3
8.3 ± 0.3
12.7 ± 0.8
< 0.001
    

1 Comparison between P6–8 and P16–18 by t-test;obtained from I-V relationships;obtained from G-V relationships.

Figure 3. ICa activation kinetics are faster in mature IHCs than immature IHCs. (A and B) Upper panels, representative traces for ICa and IBa for P6–8 (gray) or P16–18 (black) IHCs. Currents were evoked by a 15-ms step to -10 mV from a holding potential of −84 mV. Dashed lines represent exponential fits of the current trace. The time constants (τ, ms) for the displayed current traces were: for ICa (A) 0.62 (P6–8) and 0.28 (P16–18); for IBa (B) 0.50 (P6–8) and 0.38 (P16–18). Lower panels, time constants for ICa (A) and IBa (B) were plotted against test voltage. For P6–8, n = 22 for ICa, 15 for IBa. For P16–18, n = 11 for ICa, 15 for IBa. *p < 0.001 by two-way ANOVA.

Figure 2. Voltage-dependent properties of ICa and IBa in mature IHCs and in immature IHCs. (A and B) Representative ICa (upper panels) and IBa (lower panels). Currents were evoked by 15– ms depolarizing pulses from a holding voltage of −84 mV. (C and D) I-V relationships for currents in (A). (E and F) G-V relationships for currents in (A and B). Tail current amplitudes were normalized to that obtained with a pulse to +50 mV (Norm. tail) and plotted against test voltage. Smooth lines in (C–F) represent curve fits from the Boltzmann equation. The parameters for the fits shown were: in (C), V = −26.6, k = −5.9, Vrev = 56.4 mV, Gmax = 4.3 nS for P6–8 (n = 22), V = −27.7, k = −5.4, Vrev = 56.1 mV, Gmax = 3.2 nS for P16–18 (n = 15); in (D), V = -32.8, k = −4.9, Vrev = 55.5 mV, Gmax = 4.3 for P6–8 (n = 22), V = −30.1 mV, k = −4.7, Vrev = 48.0 mV, Gmax = 3.3 for P16–18 (n = 15); in (E), V = −24.1 mV, k = 9.5 for P6–8 (n = 22), V = −19.0 mV, k = 13.1 for P16–18 (n = 9); in (F), V = −29.2 mV, k = 8.4 for P6–8 (n = 11), V = −23.2 mV, k = 9.6 for P16–18 (n = 15). 1 Comparison between P6–8 and P16–18 by t-test;obtained from I-V relationships;obtained from G-V relationships. Figure 3. ICa activation kinetics are faster in mature IHCs than immature IHCs. (A and B) Upper panels, representative traces for ICa and IBa for P6–8 (gray) or P16–18 (black) IHCs. Currents were evoked by a 15-ms step to -10 mV from a holding potential of −84 mV. Dashed lines represent exponential fits of the current trace. The time constants (τ, ms) for the displayed current traces were: for ICa (A) 0.62 (P6–8) and 0.28 (P16–18); for IBa (B) 0.50 (P6–8) and 0.38 (P16–18). Lower panels, time constants for ICa (A) and IBa (B) were plotted against test voltage. For P6–8, n = 22 for ICa, 15 for IBa. For P16–18, n = 11 for ICa, 15 for IBa. *p < 0.001 by two-way ANOVA.

Ca2+-dependent inactivation is greater in mature IHCs than immature IHCs

To determine if Cav1.3 inactivation was also subject to developmental regulation in mouse IHCs, we compared the extent to which ICa and IBa inactivated in response to sustained depolarizations. Like other Cav1 channels, Cav1.3 undergoes inactivation due to Ca2+- or voltage-dependent mechanisms (CDI and VDI, respectively). CDI manifests as stronger inactivation of ICa compared with IBa, due to Ca2+ binding to the calmodulin that is associated with the channel protein. Unlike ICa, which undergoes both CDI and VDI, IBa exhibits purely VDI since Ba2+ substitutes poorly for Ca2+ in binding to calmodulin. We measured CDI and VDI with a triple-pulse voltage-protocol in which ICa or IBa was evoked by test pulses before (p1) and after (p2) a 200-ms prepulse to varying voltages. Inactivation was measured as the ratio of the p2/p1 current amplitudes; this ratio was less than 1 for prepulses inducing inactivation (Fig. 4A and B). As expected for CDI, the prepulse-voltage dependence of ICa inactivation was U-shaped and was greatest for prepulses evoking the maximal inward ICa. In contrast, inactivation of IBa with this protocol was not evident across the full prepulse voltage range. In mature IHCs, IBa underwent facilitation (p2/p1 > 1) at positive prepulse voltages, likely due to voltage-dependent facilitation (VDF). Since ICa is thought to undergo VDI as well as VDF, we isolated the effects of CDI on ICa as the difference in p2/p1 for ICa and IBa (F, Fig. 4C). By this metric, CDI was significantly greater in mature IHCs than in immature IHCs (p < 0.001 by two-way ANOVA).

Figure 4. CDI is greater in mature IHCs than immature IHCs. (A) Top panel, Voltage protocol in which test currents were evoked by pulses (p1, p2) from −84 mV to −20 mV (for ICa) or −30 mV (for IBa) before and after a 200-ms prepulse to various voltages. Bottom panels, representative traces for ICa or IBa recorded in P6–8 or P16–18 mouse IHCs. Currents were evoked by p1 (black) and p2 (red) overlaid for comparison. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (B) Inactivation was measured as the ratio of P2/P1 current amplitude and plotted against prepulse voltage. Results are from mouse IHCs from P6–8 (n = 20 for ICa, n = 6 for IBa) or P16–18 (n = 18 for ICa, n = 8 for IBa). (C) CDI was measured as the difference in p2/p1 for ICa and IBa (FCDI) and is plotted against prepulse voltage for P6–8 and P16–18 IHCs. *p < 0.05 by two-way ANOVA and post-hoc Bonferroni t-test.

Figure 4. CDI is greater in mature IHCs than immature IHCs. (A) Top panel, Voltage protocol in which test currents were evoked by pulses (p1, p2) from −84 mV to −20 mV (for ICa) or −30 mV (for IBa) before and after a 200-ms prepulse to various voltages. Bottom panels, representative traces for ICa or IBa recorded in P6–8 or P16–18 mouse IHCs. Currents were evoked by p1 (black) and p2 (red) overlaid for comparison. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (B) Inactivation was measured as the ratio of P2/P1 current amplitude and plotted against prepulse voltage. Results are from mouse IHCs from P6–8 (n = 20 for ICa, n = 6 for IBa) or P16–18 (n = 18 for ICa, n = 8 for IBa). (C) CDI was measured as the difference in p2/p1 for ICa and IBa (FCDI) and is plotted against prepulse voltage for P6–8 and P16–18 IHCs. *p < 0.05 by two-way ANOVA and post-hoc Bonferroni t-test. To address the underlying mechanism(s) for the age-dependent increase in CDI, we analyzed the onset of ICa inactivation by obtaining p2/p1 ratios in voltage protocols with prepulses of varying duration (Fig. 5A). The prepulse was set to −20 mV for ICa and −30 mV for IBa, to partially compensate for the negative shift in activation voltages for IBa compared with ICa (Table 1). The duration of the p1 and p2 test pulse was increased to 5 ms in these experiments to ensure that test currents reached steady-state levels, as long prepulses tended to slow the activation kinetics of the p2 current. The onset of inactivation was obtained by plotting p2/p1 ratios for ICa against prepulse duration. With this protocol, ICa inactivated with a double exponential time course in both immature and mature IHCs. Both fast and slow inactivation were likely influenced by CDI: the fast component was not observed for IBa, and the slow component of ICa inactivation was significantly faster than that for IBa (τslow 2.0 ± 0.4 sec for ICa vs. 3.1 ± 0.6 sec for IBa, P6–8, p = 0.15; τslow = 0.8 ± 0.13 sec for ICa vs. 2.3 ± 0.4 sec for IBa, P16–18, p < 0.001; both by t-test). While there was no age-dependent difference in the time constants for IBa inactivation (p = 0.3), both the slow and fast time constants were significantly faster for ICa inactivation in mature IHCs than in immature IHCs (Fig. 5C, p < 0.05). However, the amplitudes of the slow and fast components of ICa inactivation did not vary with age (Afast = −0.25 ± 0.01 for P6–8 vs. −0.23 ± 0.02 for P16–18, p = 0.20; Aslow = −0.40 ± 0.03 for P6–8 vs. −0.34 ± 0.01 for P16–18, p = 0.31; both by t-test). These results indicate that CDI is governed by fast and slow processes, both of which occur more rapidly in mature IHCs compared with in immature IHCs.

Figure 5. Onset of CDI is faster in mature IHCs than in immature IHCs. (A) Top panel, Voltage protocol in which test currents were evoked by pulses (p1, p2) from −84 mV to −20 mV (for ICa) or −30 mV (for IBa) before and after a prepulse to −10 mV of varying durations. Bottom panels, representative traces for ICa or IBa recorded in P6–8 or P16–18 mouse IHCs with protocols using the indicated prepulse durations. Currents evoked by p1 (black) and p2 (red) are overlaid for comparison. Scale bars, 0.8 nA (vertical), 2.5 ms (horizontal). (B) Onset of inactivation was measured by plotting p2/p1 values against prepulse duration. Smooth line represents fit with a double (ICa) or single (IBa) exponential function. For P6–8, curve fit parameters for ICa were y0 = 0.34, Afast = 0.25, τfast = 32.9 ms, Aslow = 0.40, τslow = 1990 ms (n = 22); for IBa, y0 = 0.91, A = 56.5, τ = 3108 ms (n = 8). For P16–18, curve fit parameters for ICa were y0 = 0.37, Afast = 0.28, τfast = 20.4 ms, Aslow = 0.34, τslow = 795 ms (n = 12); for IBa, y0 = 0.79, A = 30.1, τ = 2313 ms (n = 11). (C) Average values from exponential fits of ICa data in (B). *p < 0.02 by Mann–Whitney rank sum test.

Figure 5. Onset of CDI is faster in mature IHCs than in immature IHCs. (A) Top panel, Voltage protocol in which test currents were evoked by pulses (p1, p2) from −84 mV to −20 mV (for ICa) or −30 mV (for IBa) before and after a prepulse to −10 mV of varying durations. Bottom panels, representative traces for ICa or IBa recorded in P6–8 or P16–18 mouse IHCs with protocols using the indicated prepulse durations. Currents evoked by p1 (black) and p2 (red) are overlaid for comparison. Scale bars, 0.8 nA (vertical), 2.5 ms (horizontal). (B) Onset of inactivation was measured by plotting p2/p1 values against prepulse duration. Smooth line represents fit with a double (ICa) or single (IBa) exponential function. For P6–8, curve fit parameters for ICa were y0 = 0.34, Afast = 0.25, τfast = 32.9 ms, Aslow = 0.40, τslow = 1990 ms (n = 22); for IBa, y0 = 0.91, A = 56.5, τ = 3108 ms (n = 8). For P16–18, curve fit parameters for ICa were y0 = 0.37, Afast = 0.28, τfast = 20.4 ms, Aslow = 0.34, τslow = 795 ms (n = 12); for IBa, y0 = 0.79, A = 30.1, τ = 2313 ms (n = 11). (C) Average values from exponential fits of ICa data in (B). *p < 0.02 by Mann–Whitney rank sum test. To analyze recovery from inactivation, p2 test currents were measured at varying intervals after the inactivating prepulse and the ratio of p2/p1 plotted against the recovery interval (Fig. 6A). The duration of the prepulse was limited to 200 ms since longer prepulses induced VDI, particularly in mature IHCs (Fig. 5A); this would complicate analyses of recovery from CDI. In single exponential fits of these data, there was no difference in the amplitude (A = 0.32 ± 0.02 for P6–8 vs. 0.37 ± 0.03 for P16–18, p = 0.40, by t-test) or time constant (τ = 425.9 ± 28.3 ms for P6–8 vs. 486.4 ± 87.7 ms for P16–18, p = 0.08, by Mann-Whitney rank sum test; Fig. 6B). These results indicate that greater CDI in mature IHCs results primarily from faster onset, rather than slower recovery, of ICa from inactivation.

Figure 6. Recovery from CDI does not differ in mature and immature IHCs. (A) Top panel, Voltage protocol in which ICa was evoked by pulses (p1, p2) from −84 mV to −20 mV before and at variable recovery intervals after a 200-ms prepulse to −10 mV. Bottom panel, representative traces for ICa recorded in P6–8 or P16–18 mouse IHCs. Currents evoked by p1 (black) and p2 (red) at the indicated recovery intervals are overlaid for comparison. Scale bars, 0.8 nA (vertical), 2.5 ms (horizontal). (B) Recovery of ICa from inactivation was measured by plotting p2/p1 for data obtained as in (A) against recovery interval. Data were fit with an exponential function (smooth line). Curve fit parameters were: for P6–8 (n = 19), y = 0.99, A; −0.321, τ = 425 ms; for P16–18 (n = 8), y = 1.0, A = −37.8, τ = 486 ms.

Figure 6. Recovery from CDI does not differ in mature and immature IHCs. (A) Top panel, Voltage protocol in which ICa was evoked by pulses (p1, p2) from −84 mV to −20 mV before and at variable recovery intervals after a 200-ms prepulse to −10 mV. Bottom panel, representative traces for ICa recorded in P6–8 or P16–18 mouse IHCs. Currents evoked by p1 (black) and p2 (red) at the indicated recovery intervals are overlaid for comparison. Scale bars, 0.8 nA (vertical), 2.5 ms (horizontal). (B) Recovery of ICa from inactivation was measured by plotting p2/p1 for data obtained as in (A) against recovery interval. Data were fit with an exponential function (smooth line). Curve fit parameters were: for P6–8 (n = 19), y = 0.99, A; −0.321, τ = 425 ms; for P16–18 (n = 8), y = 1.0, A = −37.8, τ = 486 ms.

Ca2+-dependent inactivation depends on local Ca2+ in mature IHCs but not immature IHCs

In heterologous expression systems, CDI of Cav1 channels is not affected by relatively high concentrations of intracellular Ca2+ buffers (i.e., 10 mM BAPTA), due to a reliance on rapid, local Ca2+ influx through individual channels. However, CDI of Cav1 currents in immature rat IHCs but not in mature gerbil IHCs is suppressed by high intracellular concentrations (10 mM) of EGTA or BAPTA., These results suggest that the Ca2+ sensitivity of Cav1 CDI may be subject to developmental regulation. To test this, we analyzed the impact of increasing Ca2+ buffering strength on CDI in mature and immature mouse IHCs using triple-pulse protocols with varying prepulse voltages. To rapidly buffer incoming Ca2+ ions, we used relatively high concentrations (10 mM) of BAPTA in the intracellular recording solution. Since BAPTA (10 mM) does not influence inactivation of IBa mediated by Cav1.3, we restricted analysis to ICa in these experiments. Compared with our standard solution with EGTA (2 mM), the BAPTA-containing solution significantly blunted CDI in immature IHCs across a range of prepulse voltages (up to ~30% between −30 and +20 mV, p < 0.05 by two-way ANOVA; Fig. 7A and B). Remarkably, this effect of BAPTA was not observed in mature IHCs (p = 0.16 by two-way ANOVA; Fig. 7A–C). These effects of BAPTA were not due to altered voltage-dependence of activation, since G-V parameters were not significantly different with BAPTA or low intracellular EGTA (Table 1, ).

Figure 7. CDI is inhibited by BAPTA in immature IHCs but not mature IHCs. (A) Top, Voltage protocol in which test currents were evoked by pulses (p1, p2) from −84 mV to −20 mV before and after a 200-ms prepulse to various voltages. Bottom, Representative traces for ICa recorded in P6–8 or P16–18 mouse IHCs with protocols using the indicated prepulse voltages. Intracellular recording solution contains 2 mM EGTA or 10 mM BAPTA. Currents evoked by p1 (black) and p2 (red) are overlaid for comparison. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (B) p2/p1 was plotted against prepulse voltage for P6–8 (n = 20 for 2 EGTA, n = 25 for 10 BAPTA) and P16–18 (n = 18 for 2 EGTA, n = 8 for BAPTA). *p < 0.05 for EGTA vs. BAPTA, by two-way ANOVA and Bonferroni t-test. (C) Representative normalized current traces obtained with 2 EGTA or 10 BAPTA. ICa was evoked by a 200-ms test pulse to −10 mV from −84 mV. (D) For P6–8 IHCs, p2/p1 ratios were plotted against ICa amplitude for 2 EGTA or 10 BAPTA. Lines represent fits by linear regression.

Figure 7. CDI is inhibited by BAPTA in immature IHCs but not mature IHCs. (A) Top, Voltage protocol in which test currents were evoked by pulses (p1, p2) from −84 mV to −20 mV before and after a 200-ms prepulse to various voltages. Bottom, Representative traces for ICa recorded in P6–8 or P16–18 mouse IHCs with protocols using the indicated prepulse voltages. Intracellular recording solution contains 2 mM EGTA or 10 mM BAPTA. Currents evoked by p1 (black) and p2 (red) are overlaid for comparison. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (B) p2/p1 was plotted against prepulse voltage for P6–8 (n = 20 for 2 EGTA, n = 25 for 10 BAPTA) and P16–18 (n = 18 for 2 EGTA, n = 8 for BAPTA). *p < 0.05 for EGTA vs. BAPTA, by two-way ANOVA and Bonferroni t-test. (C) Representative normalized current traces obtained with 2 EGTA or 10 BAPTA. ICa was evoked by a 200-ms test pulse to −10 mV from −84 mV. (D) For P6–8 IHCs, p2/p1 ratios were plotted against ICa amplitude for 2 EGTA or 10 BAPTA. Lines represent fits by linear regression. The BAPTA-sensitivity of CDI in immature but not mature IHCs suggests that Ca2+ elevations that support CDI are not restricted to local Ca2+ influx through single channels but rather global Ca2+ signals fueled by multiple neighboring channels. In this respect, Cav1.3 CDI in immature IHCs may be similar mechanistically to CDI of Cav2.1 channels, which is strongly suppressed by high concentrations of BAPTA or EGTA.- If so, CDI should increase with channel density in immature IHCs. Consistent with this prediction, p2/p1 ratios decreased (i.e., inactivation increased) with increasing ICa amplitude (Fig. 7D). BAPTA caused a significant increase in the slope of the p2/p1 vs. ICa relationship (4 × 10−4 for EGTA vs. 9.5 × 10−4 for BAPTA, p < 0.03 by ANCOVA; Fig. 7D). These results show that BAPTA increases the current-amplitude dependence of CDI, such that small-amplitude ICa showed weaker CDI (and BAPTA-sensitivity) than large-amplitude ICa. To determine if the sensitivity of CDI to BAPTA in immature IHCs was due to effects of BAPTA on the onset and/or recovery kinetics of ICa inactivation, we compared these parameters using either 2 mM EGTA or 10 mM BAPTA in the intracellular recording solution. With BAPTA, the onset of inactivation exhibited a double exponential time course as was found for EGTA (Figs. 5 and 8A–C). In these experiments, BAPTA did not affect either the slow or fast time constants (τfast = 48.1 ± 9.2 ms for BAPTA vs. 32.9 ± 3.9 ms for EGTA, p = 0.06; τslow = 1.2 ± 0.3 ms for BAPTA vs. 2.0 ± 0.5 ms for EGTA, p = 0.07, both by Mann–Whitney rank sum test; Fig. 8C). However, BAPTA significantly decreased the corresponding amplitudes (Afast = 0.15 ± 0.02 for BAPTA vs. 0.25 ± 0.01 for EGTA, p < 0.001; Aslow = 0.20 ± 0.01 for BAPTA vs. 0.40 ± 0.03 for EGTA, p < 0.001, both by Mann-Whitney rank sum test) and increased the available current (Y0 = 0.66 ± 0.02 for BAPTA vs. 0.34 ± 0.04 for EGTA, p < 0.001, by Mann–Whitney rank sum test; Fig. 8C). In addition, BAPTA accelerated recovery of ICa from inactivation (τ = 271.9 ± 28.3 ms for BAPTA vs. 425.9 ± 28.3 ms for EGTA, p < 0.001 by t-test; Fig. 8D–F). Thus, BAPTA increases Cav1.3 channel availability in immature IHCs by inhibiting the amount of ICa inactivation as well as by speeding recovery from CDI. Our results highlight age-dependent differences in the intrinsic properties and modulation of Cav1.3 channels in mouse IHCs that may be important for the normal function and/or maturation of these cells as sound-transducers in the inner ear.

Figure 8. BAPTA slows the onset and accelerates recovery of CDI in immature IHCs. (A) Voltage protocol and representative p1 and p2 current traces for ICa with the indicated prepulse durations. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (B) Graph shows data plotted as in Figure 4B for ICa recorded with 2 EGTA (n = 22) or 10 BAPTA (n = 14). Smooth line represents double exponential curve fit (for 10 BAPTA, y0 = 0.66, A = 0.14, τfast = 48.1 ms, A = 0.20, τslow = 1251 ms; see Figure 4B for parameters for 2 EGTA). (C) Average parameters for exponential fits of data in (B).*p < 0.001 by Mann-Whitney rank sum test. (D) Voltage protocol and representative p1 and p2 current traces for ICa with the indicated recovery intervals. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (E) Graph shows data plotted as in Figure 5B for ICa recorded with 2 EGTA (n = 8) or 10 BAPTA (n = 14). Smooth line represents exponential curve fit (y0 = 1.0, A = −0.25, τ = 271 ms see Fig. 5B for parameters for 2 EGTA). (F) Average parameters for exponential fits of data in (E).*p < 0.001 by t- test.

Figure 8. BAPTA slows the onset and accelerates recovery of CDI in immature IHCs. (A) Voltage protocol and representative p1 and p2 current traces for ICa with the indicated prepulse durations. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (B) Graph shows data plotted as in Figure 4B for ICa recorded with 2 EGTA (n = 22) or 10 BAPTA (n = 14). Smooth line represents double exponential curve fit (for 10 BAPTA, y0 = 0.66, A = 0.14, τfast = 48.1 ms, A = 0.20, τslow = 1251 ms; see Figure 4B for parameters for 2 EGTA). (C) Average parameters for exponential fits of data in (B).*p < 0.001 by Mann-Whitney rank sum test. (D) Voltage protocol and representative p1 and p2 current traces for ICa with the indicated recovery intervals. Scale bars, 0.2 nA (vertical), 2.5 ms (horizontal). (E) Graph shows data plotted as in Figure 5B for ICa recorded with 2 EGTA (n = 8) or 10 BAPTA (n = 14). Smooth line represents exponential curve fit (y0 = 1.0, A = −0.25, τ = 271 ms see Fig. 5B for parameters for 2 EGTA). (F) Average parameters for exponential fits of data in (E).*p < 0.001 by t- test.

Discussion

The aim of the present study was to characterize the biophysical properties of Cav1.3 channels in mouse IHCs before and after the onset of hearing. While comprehensive analyses of Cav1 currents have been performed in auditory hair cells from other species,,, details regarding the function and modulation of Cav1.3 channels in immature and mature mouse IHCs is necessary to understand the sequelae associated with dysregulated Ca2+ signaling in mouse models of deafness. Our results indicate that Cav1.3 channels undergo significant changes in activation and inactivation that may support distinct roles of these channels at different stages of development.

Technical considerations and comparisons with other species

Due to the concentration of Ca2+ or Ba2+ (5 mM) in our extracellular recording solution and the fact that our recordings were performed at room temperature (~25°C), parameters for ICa and IBa activation and inactivation in the present study differ from those expected under physiological conditions (~1.3 mM extracellular Ca2+, ~37°C). In addition to increasing the amplitudes of ICa and IBa, the higher than physiological concentration of extracellular permeant ions would cause a positive shift in the half-maximal activation voltage (V) due to increased neutralization of cell surface charges. Subsequently, the voltage-dependence of time constants for activation and inactivation should be positively shifted with 5 mM compared with 1.3 mM extracellular Ca2+ or Ba2+. However, charge-screening effects of higher divalent concentrations should not influence the voltage-sensitivity of Cav1.3 activation, which is reflected by the steepness of the G-V curves (k from Boltzmann fits)., Assuming that Cav1.3 properties in mature and immature IHCs would be equally affected by the increased Ca2+ or Ba2+ concentration, we would expect our results to accurately report the age-dependent difference, if not the absolute values, pertaining to Cav1.3 properties. As shown previously,, recordings at room temperature (~25°C) would cause smaller Cav1 current amplitudes and slower activation and inactivation kinetics than at physiological temperature (~37°C). At the same time, signaling processes that post-translationally alter the intrinsic biophysical properties of Cav1.3 channels would proceed more rapidly at 37°C than at 25°C. This could be a concern given that Cav1 amplitudes in immature IHCs show greater temperature sensitivity (larger Q10) than in mature IHCs in the gerbil. Notably, we observed greater run-up of ICa upon initiation of whole-cell recordings in immature compared with mature IHCs (Fig. 1). Cav1 channel run-up has been reported in turtle and frog hair cells, and in cardiac myocytes (see for example ref. 40). While the underlying mechanisms are not entirely clear, run-up of cardiac Cav1 currents is associated with patch rupture in whole-cell recordings and exhibits a rapid (< 5 min) and late (> 10 min) phase, the latter of which is not observed at lower than physiological temperatures. Therefore, our recordings at room temperature may minimize alterations in channel properties resulting from intracellular dialysis. Our results in mouse IHCs may not be entirely consistent with those reported for gerbil and rat IHCs due to methodological and/or species-related differences. For example, the age-dependent acceleration in ICa activation kinetics in our study (Fig. 3) agrees with results from gerbil IHCs but not rat IHCs, in which ICa activation was slower after hearing onset than before. In addition, while we found CDI to be greater in mature IHCs than in immature IHCs (Fig. 4), there was no such age-related difference in gerbil IHCs, and CDI was actually greater in immature IHCs than in mature IHCs in the rat. Our results regarding the Ca2+ buffer-sensitivity of CDI in immature but not in mature mouse IHCs (Figs. 7 and 8) are consistent with these previous studies: high concentrations of BAPTA (5 mM) did not affect CDI in mature gerbil IHCs but did significantly suppress CDI in immature rat IHCs. Therefore, the shift in CDI dependence on global Ca2+ signals in immature IHCs, to local Ca2+ signals in mature IHCs, may be a fundamental feature of IHC development.

Possible mechanisms for developmental alterations in Cav1.3 function

The properties of Cav1 channels are subject to multiple forms of regulation, which could account for the difference in Cav1.3 properties we noted during mouse IHC development. We showed previously that the PDZ-domain containing protein harmonin interacts with Cav1.3 channels in mouse IHCs after hearing onset and inhibits IBa. In mature mouse IHCs, harmonin enhances proteosomal degradation of Cav1.3, which could contribute to the age-dependent decrease in ICa or IBa current density (Fig. 2C and D). A second possibility is related to alternative splicing of the pore-forming Cav1.3 α1 subunit (α11.3), which produces variants that differ in their biophysical properties and modulation.,- After hearing onset, there may be an upregulation of α11.3 variants lacking portions of a C-terminal modulatory domain (CTM), which exhibit decreased current density relative to variants with the intact CTM., However, it is also possible that factors regulating the transcription/translation of Cav1.3 channels could also vary in mouse IHCs with age. Some CTM-lacking variants exhibit enhanced voltage-dependence of activation and stronger CDI than variants containing the entire CTM. Such variants could account for increased CDI in mature IHCs (Fig. 4), but their hyperpolarized activation properties relative to the CTM-containing variants are inconsistent with our findings of weaker voltage-dependent activation of Cav1.3 currents in mature than in immature mouse IHCs (Table 1). Alternative splicing and RNA editing of the calmodulin-binding IQ domain α11.3 also produce Cav1.3 variants with limited CDI,, although the extent to which these variants are present in immature mouse IHCs is unknown. Cav1.3 channels interact with a variety of regulatory proteins, which may also influence CDI. Rab 3-interacting molecule (RIM2α) inhibits CDI when coexpressed with Cav1.3 channels in HEK293 cells. RIM2α transcripts were detected in immature but not mature IHCs and so could be responsible for the more moderate CDI in mouse IHCs prior to hearing onset (Fig. 4). Other possibilities include Ca2+ binding proteins related to calmodulin (CaBPs),,, and various synaptic proteins, which also suppress inactivation of Cav1.3 in heterologous expression systems. Whether such Cav1.3 modulatory proteins undergo developmental changes in expression remains to be elucidated. The BAPTA-sensitivity of CDI in immature IHCs (Figs. 7 and 8) contrasts with the notion that Cav1 channel CDI is largely mediated by local Ca2+ influx through single channels. In heterologous systems, Cav1.3 CDI is spared by high concentrations (10 mM) intracellular BAPTA due to a molecular determinant in the cytoplasmic N-terminal domain of α11.3 (N-terminal spatial Ca2+ transforming element, NSCaTE). Binding of the N-terminal lobe of calmodulin to NSCaTE is thought to alter the Ca2+ binding properties of calmodulin such that CDI is determined by rapid local increases in Ca2+ that cannot be buffered by BAPTA. Deletion of NSCaTE from α11.3 transforms the spatial selectivity of Cav1.3 CDI such that it can be blunted by BAPTA. While α11.3 splice variants lacking NSCaTE remain to be identified, their presence in immature but not mature IHCs could explain the BAPTA sensitivity of CDI in the former and not the latter. A second possibility relates to the increase in synaptic clustering of Cav1.3 channels in mouse IHCs after hearing onset., In frog auditory hair cells, synchronous multivesicular release occurs even in the presence of 10 mM BAPTA, which is attributed to a role of the ribbon as a barrier for Ca2+ diffusion. Cav1.3 channels anchored near the ribbon may therefore be influenced by rapidly accumulating Ca2+ nanodomains that promote single-channel CDI in mature IHCs. In contrast, a large fraction of Cav1.3 channels are extrasynaptically localized prior to hearing onset, where the absence of the ribbon may allow for faster Ca2+ diffusion away from open channels and slower elevations in Ca2+ that can be buffered by BAPTA.

Physiological significance of age-dependent changes in Cav1.3 properties and modulation

The distinct properties of Cav1.3 channels we describe in immature and mature mouse IHCs may support the varying roles of these channels during development. Prior to hearing onset, Cav1.3 channels mediate spontaneous Ca2+-dependent action potentials, which support exocytosis, and synaptic activity in the auditory pathway. Raising the concentration of Ca2+ in the extracellular recording solution from 1.3 to 5 mM increases the amplitude and accelerates the upstroke and repolarization, and enhances the frequency of the presensory action potentials in mouse IHCs. Therefore, the increased ICa density and activation and stronger voltage-dependent activation in the immature compared with in mature IHCs (Fig. 2C and D; Table 1) may be required to maintain the shape and timing of the action potential waveforms. Cav1.3 Ca2+ influx enhances repolarization of the action potential through coupling to the activation of SK Ca2+ activation K+ channels. Based on the ability of BAPTA to suppress Cav1.3-dependent activation of SK channels, Cav1.3 channels may be localized ~40 nm from SK channels. This is in contrast to the tighter coupling of nicotinic acetylcholine receptors (~13 nm distance), which also conduct Ca2+ that activates SK channels., In this context, the reduced CDI prior to hearing onset (Fig. 4) would allow for more prolonged Ca2+ signals that support SK channel activation and efficient Ca2+ spiking. In addition, sustained ICa in immature IHCs may support activity-dependent gene transcription, a hallmark function of Cav1 channels in the central nervous system. Cav1.3 channels are required for normal levels of BK K+ channel transcription in mouse IHCs, and BK channel expression in muscle is regulated by the Ca2+-dependent gene transcription factor, nuclear factor of activated T-cells (NFAT3). Future studies analyzing gene expression differences in mature and immature IHCs would help identify Ca2+-regulated transcripts that may be important for IHC development. In mature IHCs, the developmental enhancement of Cav1.3 activation kinetics (Fig. 3) and CDI (Fig. 4) may improve the temporal aspects of sound coding. In paired, pre- and postsynaptic recording at the IHC synapse, faster Cav1.3 activation correlates with decreased latency of postsynaptic responses, which supports the ability of auditory nerve fibers to fire at particular times during low-frequency stimuli (phase-locking). While Cav1.3 CDI would be expected to limit exocytosis by restricting Ca2+ influx, CDI is expected to contribute modestly to depression at the IHC synapse.,, Rather, CDI may help shape Ca2+ signals required for appropriate rates of vesicle replenishment at the ribbon, and/or help limit Ca2+ loads that could provoke metabolic stress. In summary, we have described key functional distinctions in the properties of Cav1.3 channels in immature and mature mouse IHCs. An understanding of how these developmental differences in Cav1.3 Ca2+ signals contribute to the maturation and function of IHCs in the auditory pathway remains an important challenge for future studies.

Materials and Methods

Ethical approval

All procedures were approved by the Institutional Animal Care and Use Committee at the University of Iowa in accordance with National Institutes of Health guidelines.

Preparation of mouse cochlear tissue

C57bl/6 mice (Harlan Laboratories; P6–8 or P16–18 males or females) were euthanized with ketamine (100 mg/kg) and xylazine (9 mg/kg), the skull was opened, and the temporal bones were dissected out and immersed in dissection solution (MEM/Glutamax-1 (Invitrogen) supplemented with 10 mM HEPES) which was preincubated at 37°C in a humidified incubator with 5% CO2 . The apical turn was dissected in fresh dissection solution and the spiral ligament removed. The tissue was then secured under a glass pin on a 15 mm round coverslip in dissection solution and incubated for 2–5 h at 37°C in a humidified incubator with 5% CO2 prior to recording.

Electrophysiological recordings

IHCs in the apical cochlear turn were visualized on an upright microscope (BX51WI, Olympus) with a 40X water-immersion objective with DIC optics. The basolateral membrane of IHCs was subject to whole-cell patch clamp recording with electrodes pulled from thick-walled borosilicate glass capillaries (1B150F, Warner Instruments). Before recording, the viability of the IHCs was confirmed by the following morphological features: uniform cell shape with a narrow neck, basal location of the nucleus, membrane birefringence, and intact stereocilia. The internal solution contained (in mM): 100 Cs-gluconate, 30 TEA-Cl, 1 MgCl2, 4 MgATP, 0.3GTP, 5 HEPES and 2 EGTA; pH was adjusted to 7.35 with CsOH; osmolarity~305 mOsm. In some experiments, 10 mM BAPTA was substituted for 2 EGTA and Cs-gluconate was reduced to 92 mM. External solution contained (in mM): 105 NaCl, 2.8 KCl, 3 CsCl, 35 TEA-Cl, 5 CaCl2 or BaCl2, 1 MgCl2, 10 glucose, and 10 HEPES supplemented with MEM Vitamins and Amino Acids at 1X; pH was adjusted to 7.4 with TEA-OH; osmolarity~310 mOsm. Under these conditions, the free intracellular Ca2+ was estimated to be less than 0.5 nM (with 2 mM intracellular EGTA) or less than 0.1 nM (with 10 mM intracellular BAPTA). On the day of recording, 4-aminopyridine (10 mM), apamin (0.3 mM) and TTX (0.5 mM, for P6–8 IHCs) were added to the external solution. Electrode resistances were 3–5 MΩ in the external solution. Data were acquired at room temperature with a HEKA EPC-10 amplifier controlled by Patchmaster software (HEKA Elektronik). Leak subtraction was done online with a P/8 protocol. Series resistance was compensated with the patch clamp circuitry (50–70%); average uncompensated series resistance was 9.64 ± 0.38 (n = 121). Currents were low-pass filtered at 5 kHz and sampled at 20 kHz. Voltages were not corrected for the liquid junction potential of −7 mV in the external recording solution. Electrophysiological data were analyzed with custom routines in IgorPro software (Wavemetrics). Current-voltage (I-V) relationships were fit with the equation: I = [G, where I is the current, G is maximum chord conductance, V is voltage, V is reversal potential, V is half-maximal activation voltage, and k is the slope factor. Conductance-voltage relationships were fit with the equation; G/G Time constants for activation and parameters for recovery from inactivation were obtained by fitting with the equation: I(t) = y, where I(t) is current at time = t, y is the offset (asymptote), A is the amplitude, and τ is the time constant. The onset of ICa inactivation was fit with a double exponential function: I(t) = y + Awhere I(t) is current at time = t, y is the offset (asymptote), A and A are the amplitudes, and τ and τ are the time constants. Average data are expressed as mean ± SEM. Statistical comparisons were done as indicated using SigmaPlot software (Systat). Click here for additional data file.
  64 in total

1.  RNA editing of the IQ domain in Ca(v)1.3 channels modulates their Ca²⁺-dependent inactivation.

Authors:  Hua Huang; Bao Zhen Tan; Yiru Shen; Jin Tao; Fengli Jiang; Ying Ying Sung; Choon Keow Ng; Manfred Raida; Georg Köhr; Miyoko Higuchi; Hadi Fatemi-Shariatpanahi; Bradley Harden; David T Yue; Tuck Wah Soong
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

2.  Recovery from short-term depression and facilitation is ultrafast and Ca2+ dependent at auditory hair cell synapses.

Authors:  Soyoun Cho; Geng-Lin Li; Henrique von Gersdorff
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

3.  Functional characterization of alternative splicing in the C terminus of L-type CaV1.3 channels.

Authors:  Bao Zhen Tan; Fengli Jiang; Ming Yeong Tan; Dejie Yu; Hua Huang; Yiru Shen; Tuck Wah Soong
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

4.  Sharp Ca²⁺ nanodomains beneath the ribbon promote highly synchronous multivesicular release at hair cell synapses.

Authors:  Cole W Graydon; Soyoun Cho; Geng-Lin Li; Bechara Kachar; Henrique von Gersdorff
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

5.  Calcium action potentials in hair cells pattern auditory neuron activity before hearing onset.

Authors:  Nicolas X Tritsch; Adrián Rodríguez-Contreras; Tom T H Crins; Han Chin Wang; J Gerard G Borst; Dwight E Bergles
Journal:  Nat Neurosci       Date:  2010-08-01       Impact factor: 24.884

6.  Transmitter release from cochlear hair cells is phase locked to cyclic stimuli of different intensities and frequencies.

Authors:  Juan D Goutman
Journal:  J Neurosci       Date:  2012-11-21       Impact factor: 6.167

7.  Calcium- and calmodulin-dependent inactivation of calcium channels in inner hair cells of the rat cochlea.

Authors:  Lisa Grant; Paul Fuchs
Journal:  J Neurophysiol       Date:  2008-03-05       Impact factor: 2.714

8.  Harmonin inhibits presynaptic Cav1.3 Ca²⁺ channels in mouse inner hair cells.

Authors:  Frederick D Gregory; Keith E Bryan; Tina Pangršič; Irina E Calin-Jageman; Tobias Moser; Amy Lee
Journal:  Nat Neurosci       Date:  2011-08-07       Impact factor: 24.884

9.  Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels.

Authors:  Gabriella Bock; Mathias Gebhart; Anja Scharinger; Wanchana Jangsangthong; Perrine Busquet; Chiara Poggiani; Simone Sartori; Matteo E Mangoni; Martina J Sinnegger-Brauns; Stefan Herzig; Jörg Striessnig; Alexandra Koschak
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

Review 10.  Exploring the dominant role of Cav1 channels in signalling to the nucleus.

Authors:  Huan Ma; Samuel Cohen; Boxing Li; Richard W Tsien
Journal:  Biosci Rep       Date:  2012-12-20       Impact factor: 3.840

View more
  5 in total

Review 1.  Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing.

Authors:  Mei-ling A Joiner; Amy Lee
Journal:  Curr Mol Pharmacol       Date:  2015       Impact factor: 3.339

2.  Retinoschisin Facilitates the Function of L-Type Voltage-Gated Calcium Channels.

Authors:  Liheng Shi; Michael L Ko; Gladys Y-P Ko
Journal:  Front Cell Neurosci       Date:  2017-08-08       Impact factor: 5.505

3.  Lonely but diverse: Cav1.3 L-type Ca(2+) channels in cochlear inner hair cells.

Authors:  Jörg Striessnig
Journal:  Channels (Austin)       Date:  2013-04-08       Impact factor: 2.581

Review 4.  Structure-function of proteins interacting with the α1 pore-forming subunit of high-voltage-activated calcium channels.

Authors:  Alan Neely; Patricia Hidalgo
Journal:  Front Physiol       Date:  2014-06-03       Impact factor: 4.566

5.  Expression and Localization of CaBP Ca2+ Binding Proteins in the Mouse Cochlea.

Authors:  Tian Yang; Elizabeth S Scholl; Ning Pan; Bernd Fritzsch; Françoise Haeseleer; Amy Lee
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.